Logo image of EMN

EASTMAN CHEMICAL CO (EMN) Stock Fundamental Analysis

NYSE:EMN - New York Stock Exchange, Inc. - US2774321002 - Common Stock - Currency: USD

97.85  +0.95 (+0.98%)

After market: 97.85 0 (0%)

Fundamental Rating

6

Overall EMN gets a fundamental rating of 6 out of 10. We evaluated EMN against 85 industry peers in the Chemicals industry. While EMN belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. EMN has a correct valuation and a medium growth rate. EMN also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

EMN had positive earnings in the past year.
In the past year EMN had a positive cash flow from operations.
EMN had positive earnings in each of the past 5 years.
EMN had a positive operating cash flow in each of the past 5 years.
EMN Yearly Net Income VS EBIT VS OCF VS FCFEMN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

1.2 Ratios

EMN has a Return On Assets of 5.95%. This is amongst the best in the industry. EMN outperforms 80.72% of its industry peers.
EMN's Return On Equity of 15.66% is amongst the best of the industry. EMN outperforms 83.13% of its industry peers.
EMN has a better Return On Invested Capital (8.93%) than 79.52% of its industry peers.
The Average Return On Invested Capital over the past 3 years for EMN is in line with the industry average of 6.80%.
The last Return On Invested Capital (8.93%) for EMN is above the 3 year average (8.36%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 5.95%
ROE 15.66%
ROIC 8.93%
ROA(3y)5.82%
ROA(5y)5.19%
ROE(3y)15.81%
ROE(5y)14.08%
ROIC(3y)8.36%
ROIC(5y)8.64%
EMN Yearly ROA, ROE, ROICEMN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20 25

1.3 Margins

Looking at the Profit Margin, with a value of 9.65%, EMN belongs to the top of the industry, outperforming 81.93% of the companies in the same industry.
EMN's Profit Margin has improved in the last couple of years.
EMN has a Operating Margin of 14.28%. This is in the better half of the industry: EMN outperforms 77.11% of its industry peers.
EMN's Operating Margin has been stable in the last couple of years.
With a Gross Margin value of 24.41%, EMN perfoms like the industry average, outperforming 44.58% of the companies in the same industry.
In the last couple of years the Gross Margin of EMN has remained more or less at the same level.
Industry RankSector Rank
OM 14.28%
PM (TTM) 9.65%
GM 24.41%
OM growth 3Y-7.23%
OM growth 5Y1.24%
PM growth 3Y5.65%
PM growth 5Y3.34%
GM growth 3Y0.75%
GM growth 5Y0.26%
EMN Yearly Profit, Operating, Gross MarginsEMN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20 25

4

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so EMN is still creating some value.
EMN has less shares outstanding than it did 1 year ago.
EMN has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, EMN has an improved debt to assets ratio.
EMN Yearly Shares OutstandingEMN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M
EMN Yearly Total Debt VS Total AssetsEMN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

An Altman-Z score of 2.66 indicates that EMN is not a great score, but indicates only limited risk for bankruptcy at the moment.
EMN has a Altman-Z score of 2.66. This is in the better half of the industry: EMN outperforms 75.90% of its industry peers.
EMN has a debt to FCF ratio of 7.29. This is a slightly negative value and a sign of low solvency as EMN would need 7.29 years to pay back of all of its debts.
With a decent Debt to FCF ratio value of 7.29, EMN is doing good in the industry, outperforming 62.65% of the companies in the same industry.
EMN has a Debt/Equity ratio of 0.79. This is a neutral value indicating EMN is somewhat dependend on debt financing.
The Debt to Equity ratio of EMN (0.79) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.79
Debt/FCF 7.29
Altman-Z 2.66
ROIC/WACC1.07
WACC8.35%
EMN Yearly LT Debt VS Equity VS FCFEMN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.3 Liquidity

A Current Ratio of 1.51 indicates that EMN should not have too much problems paying its short term obligations.
EMN's Current ratio of 1.51 is on the low side compared to the rest of the industry. EMN is outperformed by 68.67% of its industry peers.
EMN has a Quick Ratio of 1.51. This is a bad value and indicates that EMN is not financially healthy enough and could expect problems in meeting its short term obligations.
EMN has a Quick ratio of 0.78. This is amonst the worse of the industry: EMN underperforms 80.72% of its industry peers.
Industry RankSector Rank
Current Ratio 1.51
Quick Ratio 0.78
EMN Yearly Current Assets VS Current LiabilitesEMN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 23.28% over the past year.
Measured over the past 5 years, EMN shows a small growth in Earnings Per Share. The EPS has been growing by 2.08% on average per year.
Looking at the last year, EMN shows a small growth in Revenue. The Revenue has grown by 1.87% in the last year.
The Revenue has been growing slightly by 0.23% on average over the past years.
EPS 1Y (TTM)23.28%
EPS 3Y-3.79%
EPS 5Y2.08%
EPS Q2Q%42.75%
Revenue 1Y (TTM)1.87%
Revenue growth 3Y-3.61%
Revenue growth 5Y0.23%
Sales Q2Q%1.72%

3.2 Future

The Earnings Per Share is expected to grow by 9.47% on average over the next years. This is quite good.
EMN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 1.60% yearly.
EPS Next Y8.58%
EPS Next 2Y9.77%
EPS Next 3Y9.75%
EPS Next 5Y9.47%
Revenue Next Year2.14%
Revenue Next 2Y3.13%
Revenue Next 3Y3.31%
Revenue Next 5Y1.6%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
EMN Yearly Revenue VS EstimatesEMN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2B 4B 6B 8B 10B
EMN Yearly EPS VS EstimatesEMN Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2 4 6 8 10

6

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 12.40, EMN is valued correctly.
Based on the Price/Earnings ratio, EMN is valued a bit cheaper than 78.31% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 29.43, EMN is valued rather cheaply.
With a Price/Forward Earnings ratio of 11.42, the valuation of EMN can be described as very reasonable.
Based on the Price/Forward Earnings ratio, EMN is valued a bit cheaper than the industry average as 74.70% of the companies are valued more expensively.
The average S&P500 Price/Forward Earnings ratio is at 22.67. EMN is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 12.4
Fwd PE 11.42
EMN Price Earnings VS Forward Price EarningsEMN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

EMN's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. EMN is cheaper than 66.27% of the companies in the same industry.
EMN's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. EMN is cheaper than 69.88% of the companies in the same industry.
Industry RankSector Rank
P/FCF 16.49
EV/EBITDA 8.39
EMN Per share dataEMN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
EMN has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)1.45
PEG (5Y)5.98
EPS Next 2Y9.77%
EPS Next 3Y9.75%

7

5. Dividend

5.1 Amount

EMN has a Yearly Dividend Yield of 3.43%.
Compared to an average industry Dividend Yield of 3.37, EMN pays a better dividend. On top of this EMN pays more dividend than 81.93% of the companies listed in the same industry.
EMN's Dividend Yield is a higher than the S&P500 average which is at 2.29.
Industry RankSector Rank
Dividend Yield 3.43%

5.2 History

The dividend of EMN has a limited annual growth rate of 5.58%.
EMN has paid a dividend for at least 10 years, which is a reliable track record.
EMN has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)5.58%
Div Incr Years14
Div Non Decr Years29
EMN Yearly Dividends per shareEMN Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1 2 3

5.3 Sustainability

41.88% of the earnings are spent on dividend by EMN. This is a bit on the high side, but may be sustainable.
The dividend of EMN is growing, but earnings are growing more, so the dividend growth is sustainable.
DP41.88%
EPS Next 2Y9.77%
EPS Next 3Y9.75%
EMN Yearly Income VS Free CF VS DividendEMN Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B
EMN Dividend Payout.EMN Dividend Payout, showing the Payout Ratio.EMN Dividend Payout.PayoutRetained Earnings

EASTMAN CHEMICAL CO

NYSE:EMN (2/28/2025, 8:04:00 PM)

After market: 97.85 0 (0%)

97.85

+0.95 (+0.98%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)01-30 2025-01-30/amc
Earnings (Next)04-23 2025-04-23/amc
Inst Owners92.8%
Inst Owner Change0.92%
Ins Owners0.72%
Ins Owner Change6.27%
Market Cap11.34B
Analysts74.4
Price Target116.98 (19.55%)
Short Float %2.57%
Short Ratio2.51
Dividend
Industry RankSector Rank
Dividend Yield 3.43%
Yearly Dividend3.26
Dividend Growth(5Y)5.58%
DP41.88%
Div Incr Years14
Div Non Decr Years29
Ex-Date03-14 2025-03-14 (0.83)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)11.33%
Min EPS beat(2)4.42%
Max EPS beat(2)18.25%
EPS beat(4)4
Avg EPS beat(4)9.89%
Min EPS beat(4)4.42%
Max EPS beat(4)18.25%
EPS beat(8)8
Avg EPS beat(8)8.96%
EPS beat(12)10
Avg EPS beat(12)3.62%
EPS beat(16)12
Avg EPS beat(16)2.91%
Revenue beat(2)1
Avg Revenue beat(2)0.2%
Min Revenue beat(2)-2.22%
Max Revenue beat(2)2.62%
Revenue beat(4)1
Avg Revenue beat(4)-0.15%
Min Revenue beat(4)-2.22%
Max Revenue beat(4)2.62%
Revenue beat(8)1
Avg Revenue beat(8)-2.31%
Revenue beat(12)3
Avg Revenue beat(12)-0.9%
Revenue beat(16)7
Avg Revenue beat(16)0.99%
PT rev (1m)1.16%
PT rev (3m)0.07%
EPS NQ rev (1m)1.31%
EPS NQ rev (3m)-1.45%
EPS NY rev (1m)-0.39%
EPS NY rev (3m)-2.31%
Revenue NQ rev (1m)-1.21%
Revenue NQ rev (3m)-2.19%
Revenue NY rev (1m)-1.52%
Revenue NY rev (3m)-2.21%
Valuation
Industry RankSector Rank
PE 12.4
Fwd PE 11.42
P/S 1.21
P/FCF 16.49
P/OCF 8.81
P/B 1.96
P/tB 10.17
EV/EBITDA 8.39
EPS(TTM)7.89
EY8.06%
EPS(NY)8.57
Fwd EY8.75%
FCF(TTM)5.94
FCFY6.07%
OCF(TTM)11.1
OCFY11.35%
SpS80.94
BVpS49.86
TBVpS9.62
PEG (NY)1.45
PEG (5Y)5.98
Profitability
Industry RankSector Rank
ROA 5.95%
ROE 15.66%
ROCE 10.72%
ROIC 8.93%
ROICexc 9.57%
ROICexgc 15.94%
OM 14.28%
PM (TTM) 9.65%
GM 24.41%
FCFM 7.33%
ROA(3y)5.82%
ROA(5y)5.19%
ROE(3y)15.81%
ROE(5y)14.08%
ROIC(3y)8.36%
ROIC(5y)8.64%
ROICexc(3y)8.83%
ROICexc(5y)9.06%
ROICexgc(3y)15.26%
ROICexgc(5y)15.76%
ROCE(3y)10.04%
ROCE(5y)10.38%
ROICexcg growth 3Y-10.23%
ROICexcg growth 5Y3.54%
ROICexc growth 3Y-9.52%
ROICexc growth 5Y5.53%
OM growth 3Y-7.23%
OM growth 5Y1.24%
PM growth 3Y5.65%
PM growth 5Y3.34%
GM growth 3Y0.75%
GM growth 5Y0.26%
F-Score6
Asset Turnover0.62
Health
Industry RankSector Rank
Debt/Equity 0.79
Debt/FCF 7.29
Debt/EBITDA 2.47
Cap/Depr 117.68%
Cap/Sales 6.38%
Interest Coverage 6.6
Cash Conversion 69.61%
Profit Quality 76.02%
Current Ratio 1.51
Quick Ratio 0.78
Altman-Z 2.66
F-Score6
WACC8.35%
ROIC/WACC1.07
Cap/Depr(3y)138.26%
Cap/Depr(5y)116.93%
Cap/Sales(3y)7.09%
Cap/Sales(5y)6.22%
Profit Quality(3y)60.45%
Profit Quality(5y)105.96%
High Growth Momentum
Growth
EPS 1Y (TTM)23.28%
EPS 3Y-3.79%
EPS 5Y2.08%
EPS Q2Q%42.75%
EPS Next Y8.58%
EPS Next 2Y9.77%
EPS Next 3Y9.75%
EPS Next 5Y9.47%
Revenue 1Y (TTM)1.87%
Revenue growth 3Y-3.61%
Revenue growth 5Y0.23%
Sales Q2Q%1.72%
Revenue Next Year2.14%
Revenue Next 2Y3.13%
Revenue Next 3Y3.31%
Revenue Next 5Y1.6%
EBIT growth 1Y31.76%
EBIT growth 3Y-10.58%
EBIT growth 5Y1.48%
EBIT Next Year54.6%
EBIT Next 3Y20.8%
EBIT Next 5Y16.92%
FCF growth 1Y26.01%
FCF growth 3Y-13.53%
FCF growth 5Y-8.61%
OCF growth 1Y-6.33%
OCF growth 3Y-7.36%
OCF growth 5Y-3.07%